Shopping Cart
- Remove All
Your shopping cart is currently empty
CAY10721 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (39% SIRT3 inhibition at 200 μM). Upregulation of SIRT3 transcription is associated with oral squamous cell carcinoma (OSCC) and breast cancer with lymph node involvement, while SIRT3 down-regulation inhibits the growth of OSCC cells and sensitizes them to radiation and chemotherapy.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $113 | 35 days | |
| 5 mg | $493 | 35 days | |
| 10 mg | $862 | 35 days | |
| 25 mg | $1,920 | 35 days |
| Description | CAY10721 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (39% SIRT3 inhibition at 200 μM). Upregulation of SIRT3 transcription is associated with oral squamous cell carcinoma (OSCC) and breast cancer with lymph node involvement, while SIRT3 down-regulation inhibits the growth of OSCC cells and sensitizes them to radiation and chemotherapy. |
| Molecular Weight | 351.38 |
| Formula | C18H13N3O3S |
| Cas No. | 848688-62-0 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: 30 mg/mL (85.38 mM), Sonication is recommended. DMF: 30 mg/mL (85.38 mM), Sonication is recommended. DMSO:PBS(pH 7.2) (1:4): 0.2 mg/mL (0.57 mM), Sonication is recommended. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.